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Recent studies implicated the existence of
adult lymphoid-primed multipotent progenitors
(LMPPs) with little or no megakaryocyte-
erythroid potential, questioning common mye-
loid and lymphoid progenitors as obligate
intermediates in hematopoietic stem cell (HSC)
lineage commitment. However, the existence
of LMPPs remains contentious. Herein, global
and single-cell analyses revealed a hierarchical
organization of transcriptional lineage pro-
grams, with downregulation of megakaryocyte-
erythroid genes from HSCs to LMPPs, sus-
tained granulocyte-monocyte priming, and
upregulation of common lymphoid (but not B
and T cell-specific) genes. These biological
and molecular relationships, implicating almost
mutual exclusion of megakaryocyte-erythroid
and lymphoid pathways, are established al-
ready in fetal hematopoiesis, as evidenced by
existence of LMPPs in fetal liver. The identifica-
tion of LMPPs and hierarchically ordered tran-
scriptional activation and downregulation of
distinct lineage programs is compatible with a
model for HSC lineage commitment in which
the probability for undergoing different lineage
commitment fates changes gradually when
progressing from HSCs to LMPPs.
INTRODUCTION
The integrity of the hematopoietic system depends on
a large number of blood cell lineages being continuously
replenished from a rare population of pluripotent hemato-
poietic stem cells (HSCs), representing a paradigm for how
multilineage diversity can be achieved from a commonstem cell through lineage commitment and subsequent
differentiation (Kondo et al., 2003).
Although extensive knowledge has been obtained with
regard to the identity and mechanisms of actions of regu-
lators of blood lineage differentiation (Laiosa et al., 2006),
the regulation of HSC lineage commitment remains elu-
sive. A key step toward identifying such regulators is to
identify the cellular pathways or intermediates in the
HSC lineage commitment or lineage restriction process.
The prevailing model for mammalian hematopoiesis pre-
dicts that commitment to a single hematopoietic lineage
necessitates that HSCs first pass through a number of
obligatory restriction sites or intermediate multipotent
progenitors (Reya et al., 2001). Such a model has been
strongly supported by the identification and characteriza-
tion of distinct common lymphoid and common myeloid
progenitors (CLPs and CMPs, respectively) (Akashi
et al., 2000; Kondo et al., 1997), leading to the proposal
that the first lineage commitment step of pluripotent
HSCs results in a strict separation into common lymphoid
and common myeloid pathways (Reya et al., 2001). How-
ever, this model hinges on all upstream multipotent stem
and progenitor cells possessing the full repertoire of
lineage potentials. Although this has been unequivocally
established to be the case for long-term repopulating
HSCs (LT-HSCs) (Osawa et al., 1996) and has been
assumed to pertain also to short-term HSCs (ST-HSCs)
and multipotent progenitors (MPPs) (Reya et al., 2001),
more recent findings have strongly implicated the existence
of MPPs with combined granulocyte-macrophage (GM)
and lymphoid potentials, but little or no megakaryocyte-
erythroid potential (MkE) (Adolfsson et al., 2005; Lai
et al., 2006; Yoshida et al., 2006), within the adult mouse
LineageSCA-1+KIT+ (LSK) HSCcompartment. In contrast,
there are as of today no reports supporting the existence
of stem or progenitor cells with combined lymphoid and
MkE but no GM potential.
The proposed existence of LSKCD34+FLT3hi lymphoid-
primed MPPs (LMPPs), questioning the classical CMP-
CLP model as an obligatory route for lineage commitment
(Adolfsson et al., 2005), has been cast into doubt byImmunity 26, 407–419, April 2007 ª2007 Elsevier Inc. 407
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LSKCD34+FLT3hi bone marrow (BM) cells have some
residual MkE potential. Specifically, single-cell in vitro
studies revealed that very rare (2%–3%) LSKCD34+FLT3hi
cells had MkE potential (Adolfsson et al., 2005), whereas
others demonstrated, when transplanting high cell num-
bers (>500 cells per mice), that BM LSKCD34+FLT3hi cells
had some in vivoMkE potential (Forsberg et al., 2006). The
LSKCD34+FLT3hi population, like any stem and progenitor
cell population, is heterogeneous, so it therefore remains
unclear whether this reflects that an infrequent progenitor
cell within the LSKCD34+FLT3hi population sustains MkE
potential, unlike LMPPs, or whether LMPPs have some re-
sidual MkE potential. Thus, there is a need to further purify,
or identify and characterize LMPPs based on alternative
and more direct investigations, rather than exclusively
based on their lineage output in biological assays.
At variance with committed progenitors, HSCs and
MPPs express (at the single-cell level) multiple lineage-
associated genetic programs, proposed to reflect their
intrinsic multilineage potentiality (Akashi et al., 2003; Hu
et al., 1997; Miyamoto et al., 2002). Importantly, if the
succession from LT-HSCs through ST-HSCs and MPPs,
prior to generation of the CLPs and CMPs, would be
accompanied exclusively by changes in self-renewing
ability and not in lineage potentials (Reya et al., 2001),
the multilineage genetic priming of LT-HSCs, ST-HSCs,
and MPPs would be expected to remain similar. Thus,
herein we explored the transcriptional lineage priming of
recently identified, phenotypically and functionally distinct
and hierarchically related LSK subsets in adult BM:
LSKCD34FLT3 LT-HSCs, LSKCD34+FLT3 ST-HSCs,
and LSKCD34+FLT3hi LMPPs (Adolfsson et al., 2005;
Yang et al., 2005). Global gene profiling of these popula-
tions revealed compellingmolecular evidence for a distinct
hierarchical organization of lineage programs, with a
gradual downregulation of MkE transcriptional priming
from LT-HSCs to LMPPs, sustained GM priming, and a
distinct upregulation of common lymphoid genes in the
LMPPs. Analysis of early-stage hematopoietic develop-
ment in the fetal liver (FL) revealed a similar hierarchy
and that the LMPPs are defined already at this early stage
of development.
RESULTS
LMPPs Are Defined during Fetal Development
Although the existence of lineage restricted lymphoid-GM
progenitors has also been implicated in fetal development
(Cumano et al., 1992; Lacaud et al., 1998; Lu et al., 2002),
it has been suggested that the earliest lineage restriction
decisions of HSCs might differ in FL and adult BM (Katsura,
2002). To investigate whether the HSC hierarchy contains
a phenotypically and functionally distinct LMPP population
already during fetal development, we analyzed the LSK
compartment in 14.5 days postcoitum (dpc) FL. Although
LT-HSCs in FL, in contrast to BM, have been demonstrated
to be CD34+ (Ogawa, 2002), we noticed that a small fraction
of LSK FL cells expressing low CD34 were predominantly408 Immunity 26, 407–419, April 2007 ª2007 Elsevier Inc.FLT3 (Figure 1A), as observed for LSKCD34 cells in
BM (Figure S1 in the Supplemental Data available online).
Thus, FL LSK cells were purified by FACS into
LSKCD34loFLT3, LSKCD34hiFLT3, and LSKCD34+FLT3hi
cells (Figure 1A). In addition, we also sorted a fourth popula-
tion of LSKCD34+FLT3lo cells to investigate its relationship
to the LSKCD34+FLT3hi population.
We first performed in vivo reconstitution studies, pri-
marily to determine which of these four populations
contained HSC activity. This was particularly important,
because previous studies had suggested that LT-HSCs
in FL were in part LSKFLT3+ (Christensen and Weissman,
2001). Transplantation of as few as 40 cells of each popu-
lation in competition with 200,000 unfractionated BM cells
established that the FL LSKCD34loFLT3 population was
highly enriched in cells with long-term multilineage recon-
stituting activity in all primary (Figure 1B), as well as sec-
ondary recipients (Figure 1C). As for mice transplanted
with FL LSKCD34hiFLT3 cells, some but not all mice
sustained long-term multilineage reconstitution in primary
recipients (Figure 1B), but only in one of these was sec-
ondary reconstitution observed (Figure 1C). The remaining
recipients reconstitutedwell in the short andmid-term, but
myeloid reconstitution was undetectable after 16 weeks
and in secondary recipients. In other experiments
(Figure S2), the separation in long-term multilineage
reconstituting activity between LSKCD34loFLT3 and
LSKCD34hiFLT3 cells was even more distinct, suggest-
ing that LT-HSCs are most highly enriched in FL
LSKCD34loFLT3 cells. Although the FL LSKCD34+FLT3lo
and LSKCD34+FLT3hi populations reconstituted the
GM lineage in the short-term, they did this with less
efficiency and durability than LSKCD34loFLT3 and
LSKCD34hiFLT3 cells and showed no long-term multili-
neage repopulating ability (Figure 1B). However, they
were relatively more efficient at rapidly reconstituting B
and particular T lymphopoiesis than FL LSKCD34hiFLT3
cells (Figure 1B), as previously demonstrated for adult
LSKCD34hiFLT3hi cells (Yang et al., 2005), identifying
them as candidate fetal LMPPs without LT-HSC activity.
Although in vivo reconstitution assays are important in
establishing whether LSK subsets have LT-HSC potential
and ability to in vivo reconstitute different blood cell line-
ages, they are not optimized to establish, at the single-
cell level, the potential of short-term multipotent pro-
genitors to produce each of the myeloid and lymphoid
lineages. Thus, we next explored the candidate FL
LMPPs, and in comparison the three other FL LSK popu-
lations, for their extent of detectable Mk, E, G, M, B, and
T cell potentials in clonal single-cell in vitro assays. Initially,
because the kinetics and conditions optimal for genera-
tion of different lineages vary, each of these lineage poten-
tials was first investigated individually. In agreement with
representing populations containing LT-HSCs and ST-
HSCs, single FL LSKCD34loFLT3 and LSKCD34hiFLT3
cells generated each of the myeloid (Mk, E, G, and M)
lineages with very high efficiencies (Figures 2A and 2B),
whereas the B and T cell potentials of LSKCD34loFLT3
(39% and 37%, respectively) and LSKCD34hiFLT3
Immunity
Hierarchical Lineage Priming in HSCsFigure 1. Distinct Multilineage Reconsti-
tution Patterns of FL LSK Subsets
(A) Boxes denote the sorting strategy used for
eachof the LSKCD34loFLT3, LSKCD34hiFLT3,
LSKCD34+FLT3lo, and LSKCD34+FLT3hi pop-
ulations (numbers indicate percentages of
total FL cells), resulting in 96% or higher purity
(right, composite figure of reanalysis of 4
populations).
(B) Lethally irradiated C57Bl/6micewere trans-
planted with 40 cells of each LSK subpopula-
tion in competition with 200,000 unfractionated
BM cells. Panels show mean ± SD percent
contribution toward total, myeloid, B cell,
and T cell reconstitution in peripheral blood
derived from transplanted LSKCD34loFLT3,
LSKCD34hiFLT3 (divided into mice revealing
LT-HSC activity and no LT-HSC activity),
LSKCD34+FLT3lo, and LSKCD34+FLT3hi cells
at 3, 5, 7, and 16 weeks after transplantation.
Numbers indicate the frequencies of reconsti-
tuted mice at 3 and 16 weeks after transplanta-
tion (next to graphs), as well as frequencies of
mice reconstituted at any time point (far right).
(C) Total and myeloid reconstitution of second-
ary recipients 12 weeks after transplantation
of half a femur equivalent of BM cells from pri-
mary recipients with long-term multilineage
reconstitution. Graphs show the mean ± SD
percent, and numbers indicate frequency of
reconstituted mice.(28% and 47%, respectively) cells were somewhat lower
than what could be expected. However, virtually all FL
LSKCD34loFLT3 and LSKCD34hiFLT3 cells generating
visible clones on OP9 and OP9-DL1 stroma (see Experi-
mental Procedures) did in fact generate B and T cells,
respectively (Figure 2). Thus, the limited clonal growth in
these assays could reflect the challenge of developing
efficient stromal assays supporting the growth of primi-
tive stem and progenitor cells, as previously suggested
by others (Katsura, 2002). FL LSKCD34+FLT3lo and
LSKCD34+FLT3hi cells generated not only G and M but
also B and T cells at very high frequencies (Figures 2C
and 2D), whereas only a small fraction of LSKCD34+FLT3lo
and virtually no LSKCD34+FLT3hi cells generated Mk and
E progeny, as previously demonstrated for adult LMPPs
(Adolfsson et al., 2005). Importantly, the inability of most
FL LSKCD34+FLT3hi cells to generate Mk and E cells
was verified through careful kinetic studies (Figure S3),
and in the case of E potential through the use and compar-
ison of two different methods for detection of E potential(May-Gru¨nwald Giemsa [MGG] and 2,7-diaminofluorene
[DAF] staining) (Figure 2 and Figure S4). Thus, as their
adult counterparts (Adolfsson et al., 2005), fetal
LSKCD34+FLT3hi cells have extensive B cell, T cell, and
GM but almost no Mk and E potential.
Although all the B, T, and GM potentials of BM
LSKCD34+FLT3hi LMPPs were not evaluated from the
same single cells, previous studies could establish the
existence of LMPPs within the adult LSKCD34+FLT3hi
compartment, althoughnot their exact frequency (Adolfsson
et al., 2005). Thus, to better evaluate the full combined
B cell, T cell, and GM potentials of fetal LSKCD34+FLT3hi
cells, we developed a new assay in which we could simul-
taneously evaluate these potentials of single sorted FL
LSKCD34+FLT3hi cells with high efficiency (Figure 3A;
Experimental Procedures). After initial cloning on the
OP9 stromal cell line to promote B cell development
(Vieira and Cumano, 2004) and subsequent culture on
OP9-DL1 cultures to reveal T cell potential (Schmitt and
Zuniga-Pflucker, 2002), as many as 79% of single FLImmunity 26, 407–419, April 2007 ª2007 Elsevier Inc. 409
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Hierarchical Lineage Priming in HSCsFigure 2. LSKCD34+ FL Cells Lose MkE Potential upon Upregulation of FLT3 Expression
Single FL LSKCD34loFLT3 (A), LSKCD34hiFLT3 (B), LSKCD34+FLT3lo (C), and LSKCD34+FLT3hi (D) cells were evaluated for their potential to
developMk, E, G,M, B, and T cells in vitro. The potentials were investigated atmultiple time points to best establish the optimal timing for each lineage
and cell population (Experimental Procedures). Based on this, Mk and E potentials were evaluated at day 8 for LSKCD34loFLT3 and
LSKCD34hiFLT3 cells and at day 6 for LSKCD34+FLT3lo and LSKCD34+FLT3hi cells, whereas GM potential was evaluated at day 12 for
LSKCD34loFLT3 cells, day 10 for LSKCD34hiFLT3 cells, and day 6 for LSKCD34+FLT3lo and LSKCD34+FLT3hi cells. Open bars show frequencies
of clones formed and closed bars show frequencies of cells with indicated lineage potential. Mean ± SEM percent values from 3–6 experiments. Also
shown are representative FACS profiles defining B cell (B220+CD19+) and T cell (NK1.1Thy1.2hiCD25hi) potentials, as well as representative cell
morphology pictures from the GM and Mk culture conditions.LSKCD34+FLT3hi cells generated hematopoietic clones.
Of these clones, as many as 48% (38% of plated cells;
Figure 3B) contained all three lineages (BTM; Figures 3B
and 3C), unequivocally demonstrating that FL LSKCD34+
FLT3hi cells largely represent LMPPs with combined B, T,
and GM potentials. Interestingly, an additional 12% of FL
LSKCD34+FLT3hi cells produced B and GM cells (BM)
but no (by FACS) detectable T lymphocytes, another 1%
produced T and GM cells (TM) but no detectable B cells,
and 8% only B and T cells (BT) in the absence of myeloid
cells (Figure 3B).
The finding of FL LSKCD34+FLT3hi cells generating BM,
TM, and BT restricted clones could be compatible with the
existence of BM, TM, and BT restricted progenitors, as410 Immunity 26, 407–419, April 2007 ª2007 Elsevier Inc.previously proposed (Katsura, 2002). However, we spec-
ulated that it was equally possible that these BM, TM,
and BT clones might at least in part rather reflect the line-
age skewing of a fraction of FL LSKCD34+FLT3hi cells with
BTM potential and/or the inability to detect low levels of
lineage-committed cells by FACS. We therefore next per-
formed PCR analysis to potentially detect expression of B,
T, and myeloid cell-specific genes to establish whether
seemingly BM, TM, and BT cell restricted clones derived
from FL LSKCD34+FLT3hi cells might in fact contain low
levels of the third lineage as well. As expected, control
GM colonies were positive for themyeloid genemyeloper-
oxidase (Mpo) but negative for expression of the B cell-
specific immunoglobulin lambda-like polypeptide 1 (Igll1)
Immunity
Hierarchical Lineage Priming in HSCsFigure 3. Single LSKCD34+FLT3hi FL
Cells Have Combined B, T, and GM
Potentials
(A) Experimental design (for details see Exper-
imental Procedures).
(B) Frequencies of single LSKCD34+FLT3hi
cells possessing different lineage potentials
based on FACS and morphology. Mean ±
SEM percent values from four experiments.
Numbers shown in brackets denote the total
number of clones with the specified lineage
combinations.
(C) A single representative BTM clone analyzed
by FACS and morphology having combined B,
T, and GM potential. All lineages were con-
firmed with lineage-specific gene-expression
analysis (Table S1, clone 9). FACS profiles
show representative myeloid cells (MAC-1+
and negative for CD19, NK1.1, CD3, CD4,
CD8, CD25, and Thy1.2), B cells (CD19+), and
T cells (NK1.1Thy1.2hiCD25hi).
(D) NK cell potential (NK1.1+DX5+CD3
and/or NK1.1+B220+CD3) of single FL
LSKCD34+FLT3hi cells grown for 14 days on
OP9 in the presence of KL, FLT3L, and IL-7.
Open bar shows cloning frequency and closed
bar frequency of cells with NK potential. Repre-
sentative FACS profiles are shown. Mean ±
SEM percent values from four experiments.and paired box gene 5 (Pax5) genes and T cell-specific
CD3 antigen, epsilon polypeptide (Cd3e), and pre-T cell
antigen receptor a (Ptcra) genes (Table S1). Importantly,
BTM clones investigated confirmed the expression of
genes for all three lineages (Table S1). Notably, of investi-
gated BM clones, a significant fraction expressed Cd3e
and/or Ptcra in addition to Igll1, Pax5, andMpo, and sim-
ilarly a fraction of TM as well as BT clones expressed
genes for all three lineages, strongly suggesting that the
frequency of cells with combined BTM potential within
the FL LSKCD34+FLT3hi population might be even higher
than the 38% verified by FACS. These data demonstrate,
at the single-cell level, that a substantial fraction of
LSKCD34+FLT3hi cells in FL represent LMPPs with a com-
bined B, T, and GM but little or no MkE potential. Notably,
we also found that 61%of single FL LSKCD34+FLT3hi cells
generated NK1.1+DX5+CD3 and/or NK1.1+B220+CD3
cells (Figure 3D), demonstrating their highNKcell potential.
Hierarchical Multilineage Transcriptional Priming
in Adult LSK Subsets
Because the existence of functionally defined LMPPs and
their implications for the roadmap of HSC lineage commit-
ment remains contentious (Forsberg et al., 2006; Laiosa
et al., 2006), we next sought to obtain evidence for multi-
lineage transcriptional priming of adult and fetal LMPPs,
distinct from that of HSCs (Hu et al., 1997).
When compared to LSKCD34FLT3 LT-HSCs and
LSKCD34+FLT3 ST-HSCs, LSKCD34+FLT3hi LMPPs in
BM are by far most efficient at rapidly reconstituting theB and T cell lineages (Yang et al., 2005). In agreement
with this, we previously identified by single-cell PCR,
a small fraction (6%) of LMPPs that coexpressed the
lymphoid interleukin 7 receptor (Il7r) and the myeloid col-
ony-stimulating factor 3 receptor (granulocyte) (Csf3r)
genes (Adolfsson et al., 2005). However, the extent of lym-
phoid priming and potential coexpression of distinct GM,
MkE, B cell, and T cell programs within the LMPPs were
not established in these and other studies of LMPPs (Lai
et al., 2006; Yoshida et al., 2006), and the multilineage
priming of BM LSKCD34FLT3 and LSKCD34+FLT3
cells was not investigated. To better identify and under-
stand the molecular events preceding the first line-
age commitment steps of adult HSCs and LMPPs,
we first purified LSKCD34FLT3, LSKCD34+FLT3, and
LSKCD34+FLT3hi cells from adult BM and subjected these
to Affymetrix-based global gene expression profiling.
Analysis showed distinct differences in gene-expression
patterns between the three LSK subpopulations (Fig-
ure S5). To avoid bias in genes classified as lineage asso-
ciated, we defined MkE, GM, and lymphoid-associated
genes based on global gene profiling of Mk, E, or GM dif-
ferentiated FDCP-mix cells (Bruno et al., 2004) and B cell
progenitor cell lines (Tsapogas et al., 2003) (Experimental
Procedures, for complete lists see Figure S6). MkE-
associated genes were more highly expressed in
LSKCD34FLT3 than in LSKCD34+FLT3 cells, and fur-
ther clearly downregulated in LSKCD34+FLT3hi LMPPs
(Figure 4, Figure S6). In contrast, lymphoid-associated
genes were consistently upregulated in LSKCD34+FLT3hiImmunity 26, 407–419, April 2007 ª2007 Elsevier Inc. 411
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cells (Figure 4; Figure S6), whereas GM-associated genes
were apparently expressed in all three LSK populations. A
similar picture of differences in lineage-associated genes
Figure 4. Hierarchical Clustering of MkE, GM, and Lymphoid-
Associated Genes in Adult BM LMPPs and HSCs
Clusters show MkE, GM, and lymphoid-associated genes having an
expression ofR50 units in at least one LSK subpopulation and being
regulated R2-fold between any two LSK subpopulations. Note that
expression levels are not directly comparable between MG-U74Av2
and MOE430 2.0 chip data. Red indicates high, blue low, and white
intermediate expression levels. (For complete lists of lineage-associated
genes and cluster with indicated expression values, see Figure S6.)412 Immunity 26, 407–419, April 2007 ª2007 Elsevier Inc.was obtained when doing the comparison directly based
on the differentially regulated genes observed between
the LSK subpopulations (Figure S7).
We next used quantitative RT-PCR (Q-RT-PCR) to in-
vestigate the expression patterns for a number of specific
transcription factors, cytokine receptors, and other regu-
lators considered to play key roles in regulating the MkE,
GM, and lymphoid lineages. The MkE-associated genes
GATA binding protein 1 (Gata1), erythropoietin receptor
(Epor), and myeloproliferative leukaemia virus oncogene
(Mpl; receptor for thrombopoietin) were all expressed at
the highest levels in BM LSKCD34FLT3 cells, reduced
in LSKCD34+FLT3 cells, and clearly downregulated or
turned off in LSKCD34+FLT3+ LMPPs (Figure 5A). Similar
results were obtained for growth factor independent 1B
(Gfi1b) and GATA binding protein 2 (Gata2) genes, both
displaying reduced expression in BM LMPPs as com-
pared to LSKCD34+FLT3 cells (Figure 5A). In contrast,
the genes for the important GM regulators Csf3r and
SFFV proviral integration 1 (Sfpi1) as well as CCAAT/
enhancer binding protein a (Cebpa) and colony-stimulating
factor 1 receptor (Csf1r) were expressed at comparable
levels in the different BM LSK subpopulations (Figure 5B).
We also investigated the status of B and T cell-
associated genes, as well as genes known to be
expressed in both early committed B and T cell progeni-
tors. Notably, in agreement with the global analysis, B
cell (Pax5 and Igll1) and T cell (Ptcra and Cd3e) lineage-
specific genes were not detectable in any of the BM LSK
subpopulations (Figure 5C), including the LMPP, distin-
guishing them from CLPs that coexpress B and T cell
genes (Kondo et al., 1997). In contrast, all four investigated
lymphoid genes (recombination activating gene 1 and 2
[Rag1, Rag2], deoxynucleotidyltransferase, terminal [Dntt],
and sterile IgH transcript) thought to be expressed prior
to B and T cell specification were upregulated in
LSKCD34+FLT3hi LMPPs (Figure 5D). Thus, global gene
profiling demonstrates a hierarchical pattern of tran-
scriptional lineage priming with downregulation of MkE
programs and upregulation of early lymphoid programs
from enriched adult HSC to LMPP populations.
Combined Lymphoid and GM but Not MkE Priming
in Single Adult LMPPs
Although the global and Q-PCR analyses demonstrated
a distinct hierarchical pattern of MkE, GM, and common
lymphoid transcriptional priming within the BM
LSKCD34FLT3, LSKCD34+FLT3, and LSKCD34+FLT3hi
populations, these analyses could not establish the
frequency of cells expressing each lineage program nor
the extent to which distinct lineage programs are co-
expressed within the same or reside in distinct cells within
each of the three LSK populations. This represents a con-
siderable limitation of such population-based molecular
analysis, as shown by the fact that any phenotypically
purified stem or progenitor populations also reveal hetero-
geneous biological potentials. We therefore performed
multiplex single-cell RT-PCR analysis (Hu et al., 1997) of
each of the three BM populations by using primers for
Immunity
Hierarchical Lineage Priming in HSCsFigure 5. Expression Levels of MkE, GM, and Lymphoid Genes in Adult BM LMPPs and HSCs
Quantitative PCR analysis of expression of MkE (A), GM (B), B and T cell (C), and common lymphoid (D) genes in FACS-purified BM LSKCD34FLT3
LT-HSCs (LT), LSKCD34+FLT3 ST-HSCs (ST), and LSKCD34+FLT3hi LMPPs (LMPP). BM Lin KIT+ cells (containing progenitor cells of different
lineages), BM CD43+AA4.1+CD19+ (pro-B) cells, and CD4+CD8+ thymocytes were used as controls. All data were normalized to the expression of
hypoxanthine guanine phosphoribosyl transferase 1 (Hprt1). Mean ± SEM percent values from at least two different sorts. Q-PCR measurements
were done in triplicates. 0 = no detectable expression after 45 cycles of PCR.Mean differences between LSK subsets higher than 2-fold are indicated.
ND = not done.2–3 genes characteristic of each lineage. The genes se-
lected (MkE: Gata1, Epor, and Von Willebrand factor
homolog [Vwf]; GM: Csf3r and Mpo; and lymphoid: Il7r,
sterile IgH transcript, and Rag1) were chosen on the basis
of their known specific roles and/or expression patterns
in each of these lineages at the postcommitment level.
Importantly, we first confirmed the restricted expression
pattern of each of these genes by analyzing their expres-
sion in different purified committed myeloid and lymphoid
progenitor cells (Table S2). Experiments also showed that
these primers detect expression of the gene of interest at
a very high frequency in committed cells expected to be
positive (Table S2).
The single-cell analysis confirmed the hierarchical pat-
tern of lineage priming observed by global gene profiling
and Q-PCR by demonstrating the highest frequency of
cells expressing MkE-associated genes in BM LSKCD34
FLT3 cells (37%), less in LSKCD34+FLT3 cells (23%), and
virtual absence of such cells in LSKCD34+FLT3hi LMPPs
(<1%; Figure 6A). In contrast, investigated GM genes were
expressed in asmuch as 81% and 93%of LSKCD34+FLT3
andLSKCD34+FLT3hi cells, respectively, ascompared toonly
33% in LSKCD34FLT3 cells (Figure 6A). Finally, although
virtually no LSKCD34FLT3 or LSKCD34+FLT3 cellsexpressed any of the lymphoid genes investigated, as many
as 31% of LSKCD34+FLT3hi LMPPs did (Figure 6A).
Themost compelling evidence for a hierarchical expres-
sion of MkE, GM, and lymphoid lineage genetic programs
was observed when investigating their coexpression
patterns (Figure 6A). MkE and GM programs were coex-
pressed in LSKCD34FLT3 and LSKCD34+FLT3 cells.
Similarly, combined GM and lymphoid priming was ob-
served in LSKCD34+FLT3hi cells, with virtually all lymphoid-
primed cells also coexpressing GM genes. In striking
contrast, no BM LSKCD34FLT3, LSKCD34+FLT3, or
LSKCD34+FLT3hi LMPPs were found to have combined
expression of the investigated MkE and lymphoid genes.
Finally, we also investigated the coexpression of the
different lineage programs with Mpl, shown to play a
dual role in hematopoiesis, being critical for maintenance
and development of not only Mk progenitors but also
HSCs (Buza-Vidas et al., 2006; Kimura et al., 1998). As
expected (Buza-Vidas et al., 2006), the highest frequency
of Mpl expression was observed in BM LSKCD34FLT3
cells (59%) followed by LSKCD34+FLT3 cells (42%), but
also a smaller fraction (17%) of LSKCD34+FLT3hi LMPPs
expressed Mpl (Figure 6B). Notably, virtually all of the
Mpl-positive LSKCD34+FLT3hi cells were GM but notImmunity 26, 407–419, April 2007 ª2007 Elsevier Inc. 413
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and Lymphoid Lineage Programs in Adult LSK Subsets
(A) Distribution of lineage programs.
(B) Coexpression of Mpl with different lineage programs. Open bars
show frequencies of cells within each LSK population having indicated
lineage priming, and black bars frequencies of cells coexpressing spe-
cific lineage programs andMpl. Expression of Kit served as an internal
positive control for the RT-PCR, thus only cells being Kit mRNA posi-
tive were further analyzed (typically 90% of investigated BM LSK
cells). Cells were scored as expressing MkE, GM, and/or lymphoid
programs based on the expression of one or more lineage-associated
genes: MkE, Gata1, Vwf, and Epor; GM, Csf3r and Mpo; lymphoid,
Rag1, sterile IgH transcript, and Il7r. Cells were, based on expressed
programs, classified as: unprimed (unpr), having no lineage program;
uni-lineage, having one program; bi-lineage, having any two programs;
or multilineage, having all programs. Mean ± SEM percent values from
two independent experiments with 88 single cells analyzed in each
experiment. NA, nonapplicable (as no cells of indicated phenotype
expressed the specified lineage program).414 Immunity 26, 407–419, April 2007 ª2007 Elsevier Inc.lymphoid primed, again demonstrating a lack of coex-
pression of MkE and lymphoid lineage programs. b-globin
(Hbb family), an MkE-associated gene family, was also
expressed at low frequencies in LSKCD34+FLT3hi cells,
but as for Mpl almost exclusively together with the
GM and not lymphoid genes (R.M., A.H., and S.E.W.J.,
unpublished data). Thus, adult BM LSKCD34FLT3,
LSKCD34+FLT3, and LSKCD34+FLT3hi LMPPs repre-
sent hierarchically related subpopulations within the
LSK HSC compartment with distinct patterns of multiline-
age transcriptional priming, most notable being the up-
regulation of common lymphoid programs in LMPPs at
a stage where MkE priming is lost but the GM program
sustained, matching the upregulation of lymphoid and
loss of MkE lineage potentials in adult LMPPs (Adolfsson
et al., 2005).
Hierarchical Transcriptional Priming Is Established
during Fetal Development
The distinct pattern of lineage potentials of FL
LSKCD34+FLT3hi cells suggested that LMPPs are defined
already in fetal development. If so, we would also predict
a similar and distinct pattern of lineage transcriptional
priming in fetal LMPPs as observed in their adult counter-
parts. Thus, we next investigated FL LSKCD34+FLT3hi
when compared to LSKCD34loFLT3, LSKCD34hiFLT3,
and LSKCD34+FLT3lo cells, because adult LMPPs coex-
press GM and lymphoid but not MkE genes. One notable
difference from the adult BM (Figure 6) was that a much
higher fraction of each FL LSK population was multiline-
age transcriptional primed and virtually no unprimed cells
were observed (Figure 7). However, as for the distinct
hierarchical organization of MkE, GM, and lymphoid pro-
grams observed in adult BM, an almost identical pattern
was observed in the FL. Specifically, MkE priming was
most prominent in LSKCD34loFLT3 cells (70%) and
gradually downregulated to become very rare (9%) in
LSKCD34+FLT3hi cells. GM priming was high (83%–
97%) in all populations, whereas lymphoid priming
was exceptionally rare (<1%) in LSKCD34loFLT3 and
LSKCD34hiFLT3 cells, observed in 14% of LSKCD34+
FLT3lo cells and in as much as 63% of single
LSKCD34+FLT3hi LMPPs. MkE and GM programs
were typically coexpressed in LSKCD34loFLT3 and
LSKCD34hiFLT3 cells, and almost all lymphoid-primed
LSKCD34+FLT3lo and LSKCD34+FLT3hi LMPPs were
also GM primed (Figure 7). As in adult BM, not a single
FL LSK cell in any of the three populations coexpressed
the investigated MkE and lymphoid genes without also
being GM primed. However, at variance with adult BM,
very rare FL LSKCD34+FLT3lo and LSKCD34+FLT3hi cells
did coexpress all three (MkE, GM, and lymphoid) pro-
grams (3% and 6%, respectively; Figure 7). It is notewor-
thy that all of these cells proved to express only one of the
three investigated MkE genes (see Figure S8 for break-
down of coexpression patterns). Thus, multilineage gene-
expression analysis at the global and single-cell level
demonstrate in adult as well as fetal LSKCD34+FLT3hi
LMPPs a multilineage transcriptional priming pattern
Immunity
Hierarchical Lineage Priming in HSCsFigure 7. Hierarchical Organization of MkE, GM, and Lymphoid Programs within Distinct Fetal LSK Subpopulations
Coexpression patterns of lineage programs in single cells from fetal LSK subpopulations. Cells were scored as expressingMkE, GM, and/or lymphoid
programs based on the expression of one or more lineage-associated genes: MkE, Gata1, Vwf, and Epor; GM, Csf3r, and Mpo; lymphoid, Rag1,
sterile IgH transcript, and Il7r. Mean ± SEM percent values from two to three independent experiments, with 88 cells of each population investigated
in each experiment.unambiguously matching their loss of MkE and upregula-
tion of lymphoid potentials.
DISCUSSION
Although the existence of distinct CMPs and CLPs is com-
patible with the first lineage commitment step of pluripo-
tent adult HSCs resulting in a strict separation of common
myeloid and common lymphoid commitment pathways,
it does not preclude that lineage commitment might also
occur through alternative cellular intermediates. A model
for adult hematopoiesis in which CMPs and CLPs are
obligatory intermediates for lineage commitment (Reya
et al., 2001) would predict that each of the LT-HSCs,
ST-HSCs, andMPPs would differ only in their self-renewal
capacity but sustain the same repertoire of lineage
potentials.
In the present study we established the multilineage
molecular priming of recently identified distinct and
hierarchical related adult BM LSKCD34FLT3,
LSKCD34+FLT3, and LSKCD34+FLT3hi cells and pro-
vided evidence for a hierarchical organization of transcrip-
tional lineage priming within these multipotent HSC and
progenitor compartments. Most notably, and in agree-
ment with the functional data for lineage potentials
(Adolfsson et al., 2005), LSKCD34+FLT3hi LMPPs when
compared to HSCs downregulate theMkE and upregulate
the lymphoid gene expression while sustaining GM
priming. The typical lymphoid-primed genes in LMPPs
are those expressed prior to B and T cell commitment.
Further, multiplex single-cell PCR demonstrated thatvirtually every adult lymphoid-primed LMPP coexpresses
GM genes, in contrast to committed T and B cell progen-
itors as well as CLPs (Kondo et al., 1997; Miyamoto et al.,
2002). Whereas previous studies had demonstrated that
enrichedpopulations ofMPPs, unlikeHSCs, express a lim-
ited repertoire of lymphoid genes (Akashi et al., 2003), the
present study at the single-cell level unequivocally estab-
lishes that this lymphoid priming occurs in a population of
LMPPs that coexpress GM but no MkE genes, and which
at the functional level sustains combined GM and lym-
phoid but little or no MkE lineage potential (Adolfsson
et al., 2005). Most noteworthy, combined lymphoid and
MkE transcriptional priming was never observed in single
adult LMPPs (or LT-HSCs and ST-HSCs).
Previous descriptions of lympho-myeloid lineage-
restricted MPPs in FL, with a combined B, monocyte
(Cumano et al., 1992), and in some cases also T cell (Kat-
sura, 2002; Lacaud et al., 1998) potential, had implicated
potentially distinct pathways for HSC lineage commitment
in FL and adult BM. However, our current and comparative
studies of BM and FL demonstrate that the recently de-
scribed GM-lymphoid-primed LSKCD34+FLT3hi LMPP in
adult BM (Adolfsson et al., 2005; Yang et al., 2005) is
defined already during fetal development and that the
distinct hierarchy of transcriptional lineage priming in the
adult LSK hierarchy is established already in the FL. In
FL LSKCD34+FLT3hi LMPPs, a very low frequency of cells
with coexpression of MkE and lymphoid genes was
observed, but without exception these were, as in adult
BM, also GM primed and expressed only one of the inves-
tigated MkE genes. This could potentially reveal a rareImmunity 26, 407–419, April 2007 ª2007 Elsevier Inc. 415
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sition from MkE to lymphoid priming, or a LMPP recently
generated from HSCs with retention of some residual
mRNA for single MkE genes. This finding is also compat-
ible with a low frequency of BM LSKCD34+FLT3hi cells
(<2%–3%) having residual MkE potential, as previously
reported (Adolfsson et al., 2005; Forsberg et al., 2006).
Regardless, through extensive studies in BM and FL, we
found compelling evidence for the existence of frequent
LSKCD34+FLT3hi LMPPs with combined priming of GM
and lymphoid but not MkE gene-expression programs,
unambiguously linking their combined GM and lymphoid
lineage potentials with GM-lymphoid-restricted gene
expression.
With the OP9 and OP9-DL1 stromal cell lines, as much
as 51% of single FL LSKCD34+FLT3hi cells generated
both GM and lymphoid progeny based on stringently val-
idated FACS and morphology criteria. The by far most
common GM-lymphoid clone produced from single
LSKCD34+FLT3hi cells produced the GM and B as well
as T cell lineages, establishing the existence of FL
LSKCD34+FLT3hi LMPPs. Based on FACS analysis, we
also observed BM- and TM- as well as BT-restricted
clones. However, PCR analysis for lineage-specific genes
suggested that many of these clones might also produce
the third lineage not detected by FACS, so the emergence
of these seemingly lineage-restricted clones could alter-
natively reflect, at least in part, the inability of the utilized
assays to optimally and simultaneously promote and un-
cover all the lineage potentials of every LSKCD34+FLT3hi
cell investigated. Whereas we, in our studies of adult
BM, investigated only LSK cells with the highest levels of
FLT3 expression (LSKCD34+FLT3hi) (Adolfsson et al.,
2005), we here also investigated the FL LSKCD34+FLT3lo
population for its pattern of lineage priming and potentials,
and we made several important observations. Based on
their repopulating ability and their lineage potentials,
LSKCD34+FLT3lo cells represent an intermediate popula-
tion between LSKCD34hiFLT3 and LSKCD34+FLT3hi
cells, a conclusion also supported by having intermediate
levels of MkE and lymphoid priming and lineage po-
tentials, but importantly MkE and lymphoid programs
were also virtually mutually exclusive within single
LSKCD34+FLT3lo cells and never coexpressed in the
absence of GM priming.
The seminal discovery of HSC-enriched populations
being uniquely multilineage primed suggested that HSCs
express low levels of important genes for multiple lineages
prior to lineage commitment (Hu et al., 1997), but its
biological significance has remained unclear. Through
detailed functional and gene-expression analysis at the
single-cell level of distinct and hierarchical related HSC
and MPP populations in FL and adult BM, the present
studies represent a step forward in understanding the
implications of multilineage transcriptional priming, first
by uncovering a further complexity as to the patterns of
multilineage priming observed in phenotypically and func-
tionally distinct HSC and MPP subsets, and second by
demonstrating how the different lineage programs are in416 Immunity 26, 407–419, April 2007 ª2007 Elsevier Inc.fact hierarchically organized within each of these com-
partments, with the GM program perhaps being the
default lineage program throughout the multipotent LSK
hierarchy. Taken together with the molecular and func-
tional data presented here and in other studies (Adolfsson
et al., 2005; Lai et al., 2006; Yoshida et al., 2006), our find-
ings could be compatible with MkE-GM and subsequent
GM-lymphoid (LMPPs) progenitors being generated
upon commitment of pluripotent HSCs, although this
remains to be demonstrated.
Notably, the multilineage priming was much more ex-
tensive in fetal than in adult HSC populations, pertaining
to all investigated LSK populations, and to MkE, GM,
and lymphoid genes, although importantly without chang-
ing the hierarchical pattern observed between different lin-
eage programs and distinct populations. Although recent
studies that used in vivo lineage tracing convincingly dem-
onstrated that a small fraction of BM LT-HSCs express
low levels of the myeloid gene lysozyme (Lyzs) (Ye et al.,
2003), it has not been possible to exclude that adult LT-
HSCs are predominantly unprimed, because of the high
frequency of phenotypically defined adult HSCs reported
to be unprimed (Akashi et al., 2003; Hu et al., 1997), con-
firmed for adult HSCs in our studies, combined with the
inability to purify HSCs to homogeneity. However, our FL
studies virtually excludes this possibility: we here find
that virtually every FL LSKCD34loFLT3 cell is trans-
criptionally lineage primed, predominantly having a com-
bined MkE and GM priming. Although this could partially
reflect that adult HSCs are more quiescent, it is unlikely
to provide the sole explanation, because the ontogeny-
related differences in lineage priming are also observed
in the more actively cycling LSKCD34hiFLT3 and
LSKCD34+FLT3hi cells.
In conclusion, based on the hierarchical pattern of tran-
scriptional lineage priming and the identification of GM-
lymphoid restricted fetal and adult LMPPs, we propose
an alternative model for HSC lineage commitment, in
which no strict restriction or branching points might exist
in theHSC hierarchy. Rather, a hierarchically ordered tran-
scriptional activation and downregulation of distinct line-
age programs is most compatible with the probability for
undergoing different lineage commitment fates, changing
gradually when progressing from LSKCD34FLT3
LT-HSCs to LSKCD34+FLT3hi LMPPs, giving rise to pref-
erentially MkE-GM and lymphoid-GM restricted pro-
genitors, respectively. This model also predicts that
although any HSC commitment fate might be possible,
the probability of certain commitment fates, in particular
MkE-lymphoid-restricted progenitors, should be excep-
tionally low, regardless of the stage in the HSC hierarchy.
Importantly, although this model implicates that the previ-
ously identified CMPs and CLPs might not represent
obligatory or even main intermediates in hematopoietic
lineage commitment, it is fully compatible with the exis-
tence of CMPs and CLPs. Although this proposed model
will need to be substantiated by direct experimental evi-
dence, it is supported by the kinetics of different blood
cell lineages emerging during evolution, ontogeny, and
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and Zapata, 1998; Yang et al., 2005).
EXPERIMENTAL PROCEDURES
FACS Purification of LSK HSC Subpopulations from BM and FL
BM cells were harvested from 11- to 14-week-old C57Bl/6 mice, and
LSKCD34FLT3, LSKCD34+FLT3, and LSKCD34+FLT3hi popula-
tions were FACS purified as previously described (Adolfsson et al.,
2005; Yang et al., 2005), resulting in 98% or higher purity of each pop-
ulation (Figure S1). Lineage depleted (Lin) or KIT-enriched E14.5 FL
cells (Supplemental Experimental Procedures) were stained against
SCA-1, KIT, CD34, and FLT3 as described (Adolfsson et al., 2005;
Yang et al., 2005), with the exception that biotinylated SCA-1 was
visualized with Streptavidin-PE-TexasRed or Streptavidin-PE-Cy7.
Cells were sorted for indicated phenotypes on a BD FACSDiVa or
BD FACSAria (BD Biosciences, San Jose, CA).
Affymetrix Gene Expression and Data Analysis
RNA was extracted as previously described for RT-Q-PCR (Adolfsson
et al., 2005), labeled, amplified, and hybridized toMOE430 2.0 Affyme-
trix gene expression arrays according to Affymetrix standard protocols
(Supplemental Experimental Procedures). Probe level expression
values were calculated with RMA (Irizarry et al., 2003). Based on pre-
vious gene-expression profiles of pre-B cell lines (Tsapogas et al.,
2003) and multipotent FDCP-mix cells (7 days after induction of differ-
entiation toward either the GM, Mk, or E lineage) (Bruno et al., 2004),
lineage-associated genes were defined (among genes having an
expression ofR100 in one group of arrays and with a lower 90% con-
fidence bound of fold change) asMkE: (Mkexpr/GMexprR 2 andMkexpr/
pre-Bexpr R 2) or (Eexpr/GMexpr R 2 and Eexpr/pre-Bexpr R 2); GM:
(GMexpr/MkexprR 2 and GMexpr/pre-BexprR 2 and GMexpr/EexprR 2);
Lymphoid: (pre-Bexpr/GMexpr R 2 and pre-Bexpr/Mkexpr R 2 and
pre-Bexpr/EexprR 2) (where Mkexp, Eexpr, GMexpr, and pre-Bexpr is the
mean expression value in arrays representing that lineage). For com-
plete sets of genes classified as lineage associated, see Figure S6.
Matching of MOE430 2.0 to MG-U74Av2 probe sets (with best match
array comparison spreadsheets provided by Affymetrix) and further
analysis was done with dChip (http://biosun1.harvard.edu/complab/
dchip/). Array data are accessible through the gene expression omni-
bus (GEO; GSE7302).
Quantitative RT-PCR
RNA extraction and RT-Q-PCR of adult BM LSKCD34FLT3,
LSKCD34+FLT3, and LSKCD34+FLT3hi cells was performed as previ-
ously described (Adolfsson et al., 2005). For TaqMan probes used, see
Supplemental Experimental Procedures.
Gene-Expression Analysis of Single Cells by Multiplex RT-PCR
Multiplex single-cell RT-PCR analysis was performed as previously
described (Adolfsson et al., 2005; Hu et al., 1997). See Supplemental
Experimental Procedures for details.
In Vivo Multilineage Reconstitution Assay
for FL LSK Subpopulations
Mouse experiments were approved by the ethical committee at Lund
University. Competitive reconstitution assays with congenic CD45.1/
CD45.2 mice were performed as previously described (Yang et al.,
2005). Peripheral blood (PB) reconstitution levels were analyzed by
staining for CD45.1, CD45.2, and B cell (B220), T cell (CD4 and
CD8), and myeloid (MAC-1) cell-surface antigens (see Supplemental
Experimental Procedures for antibody information). Secondary trans-
plantations were performed as previously described (Bryder and
Jacobsen, 2000). For each lineage, >0.02% test cell contribution
(and >10 positive test cell-derived events within correct scatter profile)
toward total PB cells was required to define mice as reconstituted. For
total reconstitution, mice were considered positive if one or more line-ages fulfilled the above criteria. Percentage of donor (test cell)-derived
reconstitution was calculated as: (% donor cells)/(% donor + %
support cells).
In Vitro Evaluation of MkE, GM, and Lymphoid Potentials
of FL LSK Subpopulations
For evaluating MkE potential, a previously described method (Adolfs-
son et al., 2005) was slightly modified. In brief, single cells were seeded
(Supplemental Experimental Procedures) in 60-well plates (Nunc Mini-
trays catalog number: 163118, Nunc A/S, Roskilde, Denmark) in 20 mL
X-vivo 15 (BioWhittaker, Walkersville, MD), 0.5% detoxified bovine
serum albumin (BSA; StemCell Technologies Inc., Vancouver, Canada)
and 10% fetal calf serum (FCS, BioWhittaker, Verviers, Belgium, or
Sigma-Aldrich, St. Louis, MO), supplemented with cytokines (50 ng/mL
KIT ligand [KL], 50 ng/mL fms-like tyrosine kinase 3 ligand [FLT3L],
50 ng/mL thrombopoietin [THPO], 5 U/mL erythropoietin [EPO], and
20 ng/mL interleukin 3 [IL-3]; for detailed cytokine information see
Supplemental Experimental Procedures). Wells were scored, with an
inverted light microscope, for clonal growth and frequency of Mk
and E cells after 4 (for LSKCD34+FLT3lo, LSKCD34+FLT3hi), 6, 8, 10
(all populations), and 12 (LSKCD34loFLT3, LSKCD34hiFLT3) days
of culture, to establish optimal time point for MkE evaluation (see
Figure S3 for LSKCD34+FLT3lo and LSKCD34+FLT3hi cells, data not
shown for LSKCD34loFLT3 and LSKCD34hiFLT3 subpopulations).
Mks were verified morphologically on May-Gru¨nwald Giemsa
(MGG)-stained cytospin preparations. E potential was evaluated by
2,7-diaminofluorene (DAF; Sigma-Aldrich) staining (Kaiho and Mizuno,
1985) (see Supplemental Experimental Procedures).
For evaluating GM potential, single cells were seeded in 60-well
plates in 20 mL X-vivo 15 supplemented with 0.5% BSA and cytokines
(KL, FLT3L, THPO, granulocyte-macrophage colony-stimulating factor
[GM-CSF], granulocyte colony-stimulating factor [G-CSF], all 50 ng/mL
and 20 ng/mL IL-3). Wells were scored, with an inverted light micro-
scope, for clonal growth after 4 (LSKCD34+FLT3lo andLSKCD34+FLT3hi),
6, 8, 10 (all populations), and 12 (LSKCD34loFLT3 and
LSKCD34hiFLT3) days of culture. The optimal read-out time point
for GM evaluation was established (data not shown) to be day 12 for
LSKCD34loFLT3 cells, day 8–10 for LSKCD34hiFLT3 cells, and day
6 for LSKCD34+FLT3lo and LSKCD34+FLT3hi cells. The frequency of
clones containing G and M cells were scored by morphologic evalua-
tion of MGG-stained cytospin preparations.
For evaluating B, NK, and T cell potential, single cells were seeded
onto 80% confluent monolayers of OP9 or OP9-DL1 stromal cells.
OP9 stromal cocultures were supplemented with 25 ng/mL KL,
25 ng/mL FLT3L, and 20 ng/mL interleukin 7 (IL-7), whereas OP9-
DL1 cocultures were supplemented with 25 ng/mL KL (only first
week) and 25 ng/mL FLT3L. Half the coculture medium was replaced
every week. Visible clones were picked at day 14 and 21 fromOP9 and
OP9-DL1 cocultures, respectively, and analyzed by FACS for B cell
(B220+CD19+), NK cell (NK1.1+DX5+CD3 and/or NK1.1+B220+CD3),
and T cell (CD4+CD8a+ and/or NK1.1Thy1.2hiCD25hi) (Rumfelt et al.,
2006) committed progeny, respectively. In addition, clones were re-
quired to have R20 gated events (of indicated cell-surface pheno-
types) with appropriate scatter profile to be scored as positive. Small
clones were cultured an additional week before being analyzed as
described.
In Vitro Combined Lineage Potentials of Single
FL LSKCD34+FLT3hi LMPPs
A switch-culture system was set up to evaluate the combined
GM, B, and T potential from single LSKCD34+FLT3hi FL cells.
LSKCD34+FLT3hi cells were seeded as single cells (Supplemental
Experimental Procedures) onto a 80% confluent OP9 monolayer in
48-well plates containing media supplemented with KL (25 ng/mL),
FLT3L (25 ng/mL), and IL-7 (20 ng/mL) as described above. After
5 days of coculture, cells from each OP9-containing well were trans-
ferred to confluent OP9-DL1 monolayer wells supplemented with
only FL (25 ng/mL). After an additional 7 days of coculture, individualImmunity 26, 407–419, April 2007 ª2007 Elsevier Inc. 417
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cells (CD19+), T cells (CD4+CD8a+ and/or NK1.1Thy1.2hiCD25hi),
and GM cells (GR-1+ and/or MAC-1+ and CD19CD3CD4CD8
CD25Thy1.2NK1.1) by FACS. At least 20 events with the appropri-
ate scatter profiles were required for each lineage to be considered as
positive. Small clones were cultured for an additional 7 days and
analyzed as described. GM potential was verified morphologically by
microscopy of MGG stained cytospin preparations.
Supplemental Data
Eight figures, two tables, and Experimental Procedures are available at
http://www.immunity.com/cgi/content/full/26/4/407/DC1/.
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